These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 31072394)

  • 21. Use of conjoint analysis to assess HIV vaccine acceptability: feasibility of an innovation in the assessment of consumer health-care preferences.
    Lee SJ; Newman PA; Comulada WS; Cunningham WE; Duan N
    Int J STD AIDS; 2012 Apr; 23(4):235-41. PubMed ID: 22581945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preventive HIV vaccine acceptability and behavioral risk compensation among a random sample of high-risk adults in Los Angeles (LA VOICES).
    Newman PA; Lee SJ; Duan N; Rudy E; Nakazono TK; Boscardin J; Kakinami L; Shoptaw S; Diamant A; Cunningham WE
    Health Serv Res; 2009 Dec; 44(6):2167-79. PubMed ID: 19780857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pediatric HIV type 1 vaccine trial acceptability among mothers in Kenya.
    Farquhar C; John-Stewart GC; John FN; Kabura MN; Kiarie JN
    AIDS Res Hum Retroviruses; 2006 Jun; 22(6):491-5. PubMed ID: 16796522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acceptance of a potential HIV/AIDS vaccine among minority women.
    Frew PM; Crosby RA; Salazar LF; Gallinot LP; Bryant LO; Holtgrave DR
    J Natl Med Assoc; 2008 Jul; 100(7):802-13. PubMed ID: 18672557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Willingness to participate in HIV therapeutic vaccine trials among HIV-infected patients on ART in China.
    Dong Y; Shen X; Guo R; Liu B; Zhu L; Wang J; Zhang L; Sun J; Zhang X; Xu J
    PLoS One; 2014; 9(11):e111321. PubMed ID: 25372044
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perception of antiretroviral generic medicines: one-day survey of HIV-infected patients and their physicians in France.
    Jacomet C; Allavena C; Peyrol F; Pereira B; Joubert LM; Bagheri H; Cotte L; Garaffo R; Gerbaud L; Dellamonica P
    PLoS One; 2015; 10(2):e0117214. PubMed ID: 25658627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A social vaccine? Social and structural contexts of HIV vaccine acceptability among most-at-risk populations in Thailand.
    Newman PA; Roungprakhon S; Tepjan S; Yim S; Walisser R
    Glob Public Health; 2012; 7(9):1009-24. PubMed ID: 22780324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Attitudes about human immunodeficiency virus immunization: the influence of health beliefs and vaccine characteristics.
    Liau A; Zimet GD; Fortenberry JD
    Sex Transm Dis; 1998 Feb; 25(2):76-81. PubMed ID: 9518382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determinants of COVID-19 vaccine acceptability among older adults living with HIV.
    Davtyan M; Frederick T; Taylor J; Christensen C; Brown BJ; Nguyen AL
    Medicine (Baltimore); 2022 Aug; 101(31):e29907. PubMed ID: 35945741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acceptability of a Future HIV Vaccine: A Rapid Scoping Review.
    Choi J; May SB; Dang BN; Markham C; McGlone M; Cuccaro PM
    J Acquir Immune Defic Syndr; 2024 Jul; 96(3):197-207. PubMed ID: 38905472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HPV vaccine acceptability in HIV-infected and HIV negative men who have sex with men (MSM) in Ireland.
    Sadlier C; Lynam A; O'Dea S; Delamere S; Quinlan M; Clarke S; Sheils O; Bergin C
    Hum Vaccin Immunother; 2016 Jun; 12(6):1536-41. PubMed ID: 27153289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parental acceptance of inactivated polio vaccine in Southeast Nigeria: a qualitative cross-sectional interventional study.
    Tagbo BN; Ughasoro MD; Esangbedo DO
    Vaccine; 2014 Oct; 32(46):6157-62. PubMed ID: 25223271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Acceptability status of early antiretroviral therapy among HIV-positive men who have sex with men].
    Jiang HH; Lü F; He HJ; Zhang DD; Zeng G; Xu P; Ma FC; Xin QQ; Cheng J; Pan XH
    Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Sep; 47(9):843-7. PubMed ID: 24351567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of therapeutic intensification followed by HIV DNA prime and rAd5 boost vaccination on HIV-specific immunity and HIV reservoir (EraMune 02): a multicentre randomised clinical trial.
    Achenbach CJ; Assoumou L; Deeks SG; Wilkin TJ; Berzins B; Casazza JP; Lambert-Niclot S; Koup RA; Costagliola D; Calvez V; Katlama C; Autran B; Murphy RL;
    Lancet HIV; 2015 Mar; 2(3):e82-91. PubMed ID: 26424549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors associated with pandemic influenza A/H1N1 vaccine coverage in a French cohort of HIV-infected patients.
    Cotte L; Voirin N; Richard C; Brochier C; Schlienger I; Lack P; Lina B; Vanhems P; Zoulim F
    Vaccine; 2011 Aug; 29(34):5638-44. PubMed ID: 21699948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stakeholders' opinions and questions regarding the anticipated malaria vaccine in Tanzania.
    Mtenga S; Kimweri A; Romore I; Ali A; Exavery A; Sicuri E; Tanner M; Abdulla S; Lusingu J; Kafuruki S
    Malar J; 2016 Apr; 15():189. PubMed ID: 27048260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV-1 Reservoir Dynamics after Vaccination and Antiretroviral Therapy Interruption Are Associated with Dendritic Cell Vaccine-Induced T Cell Responses.
    Andrés C; Plana M; Guardo AC; Alvarez-Fernández C; Climent N; Gallart T; León A; Clotet B; Autran B; Chomont N; Gatell JM; Sánchez-Palomino S; García F
    J Virol; 2015 Sep; 89(18):9189-99. PubMed ID: 26109727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Health beliefs and intention to get immunized for HIV.
    Zimet GD; Liau A; Fortenberry VD
    J Adolesc Health; 1997 May; 20(5):354-9. PubMed ID: 9168382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predicting hypothetical willingness to participate (WTP) in a future phase III HIV vaccine trial among high-risk adolescents.
    Giocos G; Kagee A; Swartz L
    AIDS Behav; 2008 Nov; 12(6):842-51. PubMed ID: 17668313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced retention strategies and willingness to participate among hard-to-reach female sex workers in Barcelona for HIV prevention and vaccine trials.
    Etcheverry MF; Evans JL; Sanchez E; Mendez-Arancibia E; Meroño M; Gatell JM; Page K; Joseph J
    Hum Vaccin Immunother; 2013 Feb; 9(2):420-9. PubMed ID: 23291931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.